Inhalation Aspects of Therapeutic Aerosols

Toxicologic Pathology

Volumn 35, Issue 1, 2007, Pages 23-26

  Leach, Chet L ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

aerosols; beta agonists; drugs; Inhalation; steroids

Indexed keywords

ANALGESIC AGENT; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CICLESONIDE; FENTANYL; FLUNISOLIDE; FLUORINATED HYDROCARBON; FLUTICASONE; INSULIN; LACTIC ACID DERIVATIVE; LIPOXYGENASE INHIBITOR; MACROGOL; MEASLES VACCINE; NICOTINE; OZONE; PHOSPHODIESTERASE IV INHIBITOR; SALBUTAMOL; SALBUTAMOL SULFATE; STEROID; SUMATRIPTAN; TETRAHYDROCANNABINOL; TRIAMCINOLONE;

AEROSOL; AIRWAY; AIRWAY DYNAMICS; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TRANSPORT; DRY POWDER; HUMAN; INHALATION; LUNG PARENCHYMA; LYMPHATIC SYSTEM; METERED DOSE INHALER; MIGRAINE; PAIN; PARTICLE SIZE; PATENT; POWDER INHALER; PRIORITY JOURNAL; SMOKING CESSATION; SUSTAINED DRUG RELEASE; TOBACCO DEPENDENCE; UNSPECIFIED SIDE EFFECT; VOMITING;

ADMINISTRATION, INHALATION; AEROSOL PROPELLANTS; HUMANS; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS;

EID: 33847281351     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230601072335     Document Type: Article

References (24)

1. Alexander DJ Safety of propellants J Aerosol Med 1995 8 Suppl 1 S41 7
2. Bennett JV de Castro JF Valdespino-Gomez JL Garcia-Garcia ML Islas-Romero R Echaniz-Aviles G Jiménez-Corona A Sepúlveda-Amor J Aerosolized measles and measles-rubella vaccines induce better measles antibody booster response than injected vaccines: randomized trials in Mexican schoolchildren Bull World Health Org 2002 80 806 12
3. Busse WW Brazinsky S Jacobson K Stricker W Schmitt K Brugt JV Donnell D Hannon S Colice GL Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant J Allergy Clin Immunol 1999 104 1215 22
4. Devadason SG Huang T Walker S Troedson R Le Soüef PN Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children Eur Respir J 2003 21 1007 11
5. Dilraj A Cutts FT de Castro JF Wheeler JG Brown D Roth C Coovadia HM Bennett JV Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomized trial Lancet 2000 355 9206 798 803
6. Dolovich MB Ahrens RC Hess DR Anderson P Dhand R Rau JL Smaldone GC Guyatt G Device selection and outcomes of aerosol therapy: evidence-based guidelines Chest 2005 127 335 71
7. Dolovich M Leach CL Busse WW Holgate ST Drug delivery devices and propellants Asthma and Rhinitis 2000 2 Boston, MA Blackwell Scientific 1719 31
8. Gabrio BJ Stein SW Velasquez D A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers Int J Pharm 1999 186 3 12
9. Hamid Q Song Y Kotimbos T Respiratory pathophysiologic responses: inflammation of small airways in asthma J Allergy Clin Immunol 1997 100 44 51
10. Hayman G Why the environment matters Br J Clin Pract 1995 49 75 2 6
11. Leach CL Approaches and challenges to use Freon propellant replacements Aerosol Sci Technol 1995 22 4 328 34
12. Leach CL Safety assessment of the HFA propellant and the new inhaler (Airomir) Eur Res Rev 1997 7 35 8
13. Leach CL Relevance of radiolabeled steroid inhalation studies to clinical outcomes J Aerosol Med 1998a 11 1 S29 34
14. Leach CL Purewal TS Grant DJ Toxicology of propellants Metered Dose Inhaler Technology 1998b Buffalo Grove, IL Interpharm Press, Inc. 229 54
15. Leach CL Davidson PJ Boudreau RJ Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone Eur Res J 1998c 12 1346 53
16. Leach CL Davidson PJ Hasselquist BE Boudreau RJ Lung deposition of HFA-Beclomethasone is greater than that of CFC-fluticasone and CFC-beclomethasone: a crossover study in healthy volunteers Chest 2002 122 2 510 16
17. Leach CL Hameister WM Tomai MA Hammerbeck DM Stefely JS Dalby RN Byron PR Farr SJ Peart J Oligolactic acid (OLA) biomatrices for sustained release of asthma therapeutics Respiratory Drug Delivery VII Proceedings 2000 Raleigh, NC Serentec Press, Inc. 75 81
18. Leach CL Kuo M Bueche B Fishburn S Viegas T Bossard M Guo L Bentley MD Hobbs CH Cherrington AD Patton JS Dalby RN Byron PR Peart J Suman JD Farr SJ Modifying the pulmonary absorption and retention of proteins through PEGylation Respiratory Drug Delivery IX Proceedings 2004 River Grove, IL Davis Healthcare Publishing 69 77
19. Manzer LE The CFC-ozone issue: progress on the development of alternatives to CFCs Science 1990 249 4964 31 5
20. Molina MJ Rowland FS Stratospheric sink for chlorofluoromethanes: chlorine atom-catalyzed destruction of ozone Nature 1974 249 5460 810 12
21. Montreal Protocol The Montreal Protocol on substances that deplete the ozone layer. Final Act (Nairobi: UNEP 1987) Federal Register 1994 59 56276 98
22. Renigunta A Krasteva G Konig P Rose F Klepetko W Grimminger F Seeger W Hanze J DNA transfer into human lung cells is improved with Tat-RGD peptide by caveoli-mediated endocytosis Bio-conjug Chem 2006 Mar–Apr 17 2 327 34
23. Shaw NJ Edmonds AT Inhaled beclomethasone and oral candidiasis Arch Dis Child 1986 61 788 90
24. Tansey I The technical transition to CFC-free inhalers Br J Clin Pract Suppl 1997 89 22 7